{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:39:19Z","timestamp":1790883559608,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Key Science Research Program of China","award":["2009CB930300"],"award-info":[{"award-number":["2009CB930300"]}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["81172991"],"award-info":[{"award-number":["81172991"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"State Key Laboratory of Drug Delivery Technology and Pharmacokinetics"},{"name":"Innovation Team of Ministry of Education","award":["BMU20110263"],"award-info":[{"award-number":["BMU20110263"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.biomaterials.2013.01.055","type":"journal-article","created":{"date-parts":[[2013,2,11]],"date-time":"2013-02-11T18:27:02Z","timestamp":1360607222000},"page":"3366-3380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways"],"prefix":"10.1016","volume":"34","author":[{"given":"Nan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Jun","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2013.01.055_bib1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008","volume":"127","author":"Shin","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.suc.2010.12.003","article-title":"Palliative care in lung cancer","volume":"91","author":"Ferrell","year":"2011","journal-title":"Surg Oncol Clin N AM"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib3","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1200\/JCO.2008.17.7162","article-title":"Chemotherapy in addition to supportive care improves survival in advanced non \u2013 small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials","volume":"26","author":"NSCLC Meta-Analyses Collaborative Group","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","article-title":"Apoptosis: a link between cancer genetics and chemotherapy","volume":"108","author":"Johnstone","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-0609.2007.00980.x","article-title":"Genetic and epigenetic alterations of the reduced folate carrier in untreated diffuse large B-cell lymphoma","volume":"80","author":"Kastrup","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib6","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1016\/j.biomaterials.2011.04.029","article-title":"The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells","volume":"32","author":"Wang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib7","first-page":"497","article-title":"Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells","volume":"66","author":"Floridi","year":"1981","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s002800050459","article-title":"Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograft","volume":"38","author":"Pratesi","year":"1996","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd3137","article-title":"Targeting mitochondria for cancer therapy","volume":"9","author":"Fulda","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib10","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.onc.1202625","article-title":"Lonidamine triggers apoptosis via a direct, Bcl-2 inhibited effect on the mitochondrial permeability transition pore","volume":"18","author":"Ravagnan","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib11","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2165\/00003495-199345050-00011","article-title":"Epirubicin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy","volume":"45","author":"Plosker","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib12","article-title":"Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating notch signaling","author":"Liu","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physrev.00013.2006","article-title":"Mitochondrial membrane permeabilization in cell death","volume":"87","author":"Kroemer","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib14","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1016\/j.biomaterials.2007.05.044","article-title":"Targeted biding of PLA microparticles with lipid-PEG-tethered ligands","volume":"28","author":"Duncanson","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2008.03.022","article-title":"A\u00a0potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes","volume":"129","author":"Liu","year":"2008","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1021\/mp100249x","article-title":"Targeting therapy with mitosomal daunorubicin plus amlodipine has the potential to circumvent intrinsic resistant breast cancer","volume":"8","author":"Zhang","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib17","first-page":"427","article-title":"High-performance liquid chromatography of lonidamine in human plasma and Urine","volume":"277","author":"Scaduto","year":"1983","journal-title":"J\u00a0Chromatogr"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejps.2010.06.008","article-title":"Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats","volume":"41","author":"Wei","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000323222","article-title":"Pharmacokinetics and tissue distribution of dual-targeting daunorubicin liposomes in mice","volume":"87","author":"Ying","year":"2011","journal-title":"Pharmacology"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib20","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib21","first-page":"3125","article-title":"The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals","volume":"6","author":"Men","year":"2011","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.biomaterials.2011.09.055","article-title":"Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells","volume":"33","author":"Zhang","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0006-3495(99)77214-0","article-title":"Measurement of mitochondrial membrane potential using fluorescent derivatives","volume":"76","author":"Scaduto","year":"1999","journal-title":"Biophys J"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-7-13","article-title":"Drugs targeting the mitochondrial pore act as cytotoxic and cytostatic agents in temozolomide-resistant glioma cells","volume":"7","author":"Lena","year":"2009","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib25","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.biomaterials.2011.10.085","article-title":"Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanoma","volume":"33","author":"Yu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.taap.2006.11.031","article-title":"Oxidized low-density lipoprotein induces apoptotic insults to mouse cerebral endothelial cells via a Bax-mitochondria-caspase protease pathway","volume":"219","author":"Chen","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib27","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bcp.2011.08.017","article-title":"Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells: reactive oxygen species generation and defensive protein kinase (MEK\/ERK, Akt\/mTOR) modulation","volume":"82","author":"Calvi\u00f1o","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib28","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/jcp.20806","article-title":"Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis","volume":"209","author":"Ramos","year":"2006","journal-title":"Cell Physiol"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib29","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0006-2952(98)00054-9","article-title":"Enhancement of doxorubicin content by the antitumor drug lonidamine in resistant Ehrlich ascites tumor cells through modulation of energy metabolism","volume":"56","author":"Floridi","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib30","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1016\/j.biomaterials.2011.01.038","article-title":"The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery","volume":"32","author":"Yao","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib31","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1073\/pnas.84.15.5444","article-title":"Dequalinium, a topical antimicrobial agent, displays anti-carcinoma activity based on selective mitochondrial accumulation","volume":"84","author":"Weiss","year":"1987","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.addr.2010.03.011","article-title":"Tumor delivery of macromolecular drugs based on the EPR effect","volume":"63","author":"Torchilin","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00665975","article-title":"Phase II study of high-dose epirubicin, lonidamine, alpha 2b interferon in advanced breast cancer","volume":"35","author":"Iaffaioli","year":"1995","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejps.2005.04.003","article-title":"Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in\u00a0vitro, in situ and in\u00a0vivo","volume":"25","author":"Varma","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib36","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1021\/mp900191s","article-title":"Vitamin E TPGS P-glycoprotein inhibition mechanism: in fluence on conformational flexibility, intracellular ATP levels, and role of time and site of access","volume":"7","author":"Collnot","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.biomaterials.2005.05.104","article-title":"Nanoparticles of poly(lactide)\/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in\u00a0vitro drug release","volume":"27","author":"Zhang","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib38","first-page":"23","article-title":"Drug resistance in lung cancer","volume":"1","author":"Manish","year":"2010","journal-title":"Lung Cancer Targets Ther"},{"key":"10.1016\/j.biomaterials.2013.01.055_bib39","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2011.03.014","article-title":"Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes","volume":"152","author":"Xiang","year":"2011","journal-title":"J\u00a0Control Release"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961213000835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961213000835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:48:04Z","timestamp":1758901684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961213000835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":39,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0142961213000835"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.01.055","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2013.01.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}